Owner Japan as represented by President of National Cancer Center Kyowa Hakko Kirin Co., Ltd

Inventors Furuya, Akiko; Hosaka, Emi; Sekine, Susumu; Ohta, So; Ota, Toshio; Shiraishi, Norihiko; Kato, Yoko; Ochiai, Atsushi; Sasaki, Yuka; Shitara, Kenya

Agent Spruson & Ferguson

Pub. Number AU-B-2005252521

PCT Pub. Number WO2005/121338

Priority 2004-168116 07.06.04 JP

Filing date 7 June 2005

Wipo publication date 22 December 2005

Acceptance publication date 21 October 2010

C12N 15/09 (2006.01) Mutation or genetic engineering - Recombinant DNA-technology

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

A61P 35/00 (2006.01) Antineoplastic agents

C07K 16/28 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

C07K 16/32 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

C07K 16/46 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies - Hybrid immunoglobulins

C12N 1/15 (2006.01) Micro-organisms, e.g. protozoa - modified by introduction of foreign genetic material

C12N 1/19 (2006.01) Micro-organisms, e.g. protozoa - modified by introduction of foreign genetic material

C12N 1/21 (2006.01) Micro-organisms, e.g. protozoa - modified by introduction of foreign genetic material

C12N 5/10 (2006.01) Undifferentiated human, animal or plant cells, e.g. cell lines - Cells modified by introduction of foreign genetic material, e.g. virus-transformed cells

C12P 21/08 (2006.01) Preparation of peptides or proteins - Monoclonal antibodies

G01N 33/53 (2006.01) Investigating or analysing materials by specific methods not covered by groups - Immunoassay

G01N 33/574 (2006.01) Investigating or analysing materials by specific methods not covered by groups - for cancer